T0	KEYPHRASE-NOTYPES 2 17	5-year-old girl
T1	KEYPHRASE-NOTYPES 26 53	significant medical history
T2	KEYPHRASE-NOTYPES 69 82	unsteady gait
T3	KEYPHRASE-NOTYPES 105 109	days
T4	KEYPHRASE-NOTYPES 119 130	examination
T5	KEYPHRASE-NOTYPES 151 157	period
T6	KEYPHRASE-NOTYPES 163 167	gait
T7	KEYPHRASE-NOTYPES 234 241	history
T8	KEYPHRASE-NOTYPES 245 250	fever
T9	KEYPHRASE-NOTYPES 252 256	rash
T10	KEYPHRASE-NOTYPES 258 278	recent immunizations
T11	KEYPHRASE-NOTYPES 285 289	bite
T12	KEYPHRASE-NOTYPES 294 303	exposures
T13	KEYPHRASE-NOTYPES 307 325	infectious disease
T14	KEYPHRASE-NOTYPES 327 342	Medical history
T15	KEYPHRASE-NOTYPES 365 371	family
T16	KEYPHRASE-NOTYPES 381 395	Silifke Mersin
T17	KEYPHRASE-NOTYPES 408 422	semiurban area
T18	KEYPHRASE-NOTYPES 426 440	southern coast
T19	KEYPHRASE-NOTYPES 444 452	Anatolia
T20	KEYPHRASE-NOTYPES 454 474	Mediterranean region
T21	KEYPHRASE-NOTYPES 477 488	Vital signs
T22	KEYPHRASE-NOTYPES 493 513	physical examination
T23	KEYPHRASE-NOTYPES 530 554	neurological examination
T24	KEYPHRASE-NOTYPES 567 583	mental functions
T25	KEYPHRASE-NOTYPES 588 611	cranial nerve functions
T26	KEYPHRASE-NOTYPES 642 647	signs
T27	KEYPHRASE-NOTYPES 651 661	meningitis
T28	KEYPHRASE-NOTYPES 671 697	bilateral cerebellar signs
T29	KEYPHRASE-NOTYPES 705 709	form
T30	KEYPHRASE-NOTYPES 713 722	hypotonia
T31	KEYPHRASE-NOTYPES 730 735	limbs
T32	KEYPHRASE-NOTYPES 737 747	dysarthria
T33	KEYPHRASE-NOTYPES 749 758	nystagmus
T34	KEYPHRASE-NOTYPES 760 779	bilateral dysmetria
T35	KEYPHRASE-NOTYPES 785 801	intention tremor
T36	KEYPHRASE-NOTYPES 822 835	marked ataxia
T37	KEYPHRASE-NOTYPES 853 873	deep tendon reflexes
T38	KEYPHRASE-NOTYPES 890 907	plantar responses
T39	KEYPHRASE-NOTYPES 913 919	flexor
T40	KEYPHRASE-NOTYPES 921 940	Laboratory analyses
T41	KEYPHRASE-NOTYPES 950 978	normal blood leukocyte count
T42	KEYPHRASE-NOTYPES 985 988	mm3
T43	KEYPHRASE-NOTYPES 991 1015	serum C-reactive protein
T44	KEYPHRASE-NOTYPES 1019 1023	mg L
T45	KEYPHRASE-NOTYPES 1030 1060	erythrocyte sedimentation rate
T46	KEYPHRASE-NOTYPES 1065 1069	mm h
T47	KEYPHRASE-NOTYPES 1089 1099	tomography
T48	KEYPHRASE-NOTYPES 1101 1103	CT
T49	KEYPHRASE-NOTYPES 1109 1135	magnetic resonance imaging
T50	KEYPHRASE-NOTYPES 1137 1140	MRI
T51	KEYPHRASE-NOTYPES 1155 1168	abnormalities
T52	KEYPHRASE-NOTYPES 1176 1181	brain
T53	KEYPHRASE-NOTYPES 1183 1202	Cerebrospinal fluid
T54	KEYPHRASE-NOTYPES 1204 1207	CSF
T55	KEYPHRASE-NOTYPES 1218 1234	mild pleocytosis
T56	KEYPHRASE-NOTYPES 1239 1248	cells mm3
T57	KEYPHRASE-NOTYPES 1271 1285	normal protein
T58	KEYPHRASE-NOTYPES 1290 1312	glucose concentrations
T59	KEYPHRASE-NOTYPES 1314 1323	Acyclovir
T60	KEYPHRASE-NOTYPES 1325 1335	cefotaxime
T61	KEYPHRASE-NOTYPES 1341 1355	clarithromycin
T62	KEYPHRASE-NOTYPES 1387 1400	Serum markers
T63	KEYPHRASE-NOTYPES 1405 1425	herpes simplex virus
T64	KEYPHRASE-NOTYPES 1427 1442	cytomegalovirus
T65	KEYPHRASE-NOTYPES 1444 1460	varicella zoster
T66	KEYPHRASE-NOTYPES 1462 1467	mumps
T67	KEYPHRASE-NOTYPES 1469 1476	rubella
T68	KEYPHRASE-NOTYPES 1478 1485	rubeola
T69	KEYPHRASE-NOTYPES 1487 1505	Epstein-Barr virus
T70	KEYPHRASE-NOTYPES 1511 1521	mycoplasma
T71	KEYPHRASE-NOTYPES 1541 1567	Intravenous immunoglobulin
T72	KEYPHRASE-NOTYPES 1569 1573	IVIG
T73	KEYPHRASE-NOTYPES 1575 1583	infusion
T74	KEYPHRASE-NOTYPES 1599 1602	day
T75	KEYPHRASE-NOTYPES 1621 1646	postviral immune response
T76	KEYPHRASE-NOTYPES 1675 1698	acute cerebellar ataxia
T77	KEYPHRASE-NOTYPES 1707 1716	fifth day
T78	KEYPHRASE-NOTYPES 1723 1732	admission
T79	KEYPHRASE-NOTYPES 1734 1754	serologic evaluation
T80	KEYPHRASE-NOTYPES 1797 1818	pathogen-specific IgM
T81	KEYPHRASE-NOTYPES 1836 1839	IgG
T82	KEYPHRASE-NOTYPES 1865 1872	results
T83	KEYPHRASE-NOTYPES 1878 1885	history
T84	KEYPHRASE-NOTYPES 1893 1900	patient
T85	KEYPHRASE-NOTYPES 1921 1930	tick bite
T86	KEYPHRASE-NOTYPES 1955 1961	injury
T87	KEYPHRASE-NOTYPES 1963 1967	rash
T88	KEYPHRASE-NOTYPES 1977 1981	bite
T89	KEYPHRASE-NOTYPES 1983 1992	Acyclovir
T90	KEYPHRASE-NOTYPES 1997 2011	clarithromycin
T91	KEYPHRASE-NOTYPES 2033 2036	day
T92	KEYPHRASE-NOTYPES 2065 2087	intravenous cefotaxime
T93	KEYPHRASE-NOTYPES 2092 2097	mg kg
T94	KEYPHRASE-NOTYPES 2102 2105	day
T95	KEYPHRASE-NOTYPES 2122 2126	days
T96	KEYPHRASE-NOTYPES 2140 2147	patient
T97	KEYPHRASE-NOTYPES 2161 2171	permission
T98	KEYPHRASE-NOTYPES 2178 2197	new lumbar puncture
T99	KEYPHRASE-NOTYPES 2199 2216	CSF Lyme serology
T100	KEYPHRASE-NOTYPES 2245 2249	gait
T101	KEYPHRASE-NOTYPES 2276 2296	cefotaxime treatment
T102	KEYPHRASE-NOTYPES 2305 2309	time
T103	KEYPHRASE-NOTYPES 2313 2322	discharge
T104	KEYPHRASE-NOTYPES 2326 2329	day
T105	KEYPHRASE-NOTYPES 2338 2360	neurologic examination
T106	KEYPHRASE-NOTYPES 2373 2378	Serum
T107	KEYPHRASE-NOTYPES 2401 2402	B
T108	KEYPHRASE-NOTYPES 2416 2419	IgM
T109	KEYPHRASE-NOTYPES 2424 2438	IgG antibodies
T110	KEYPHRASE-NOTYPES 2442 2445	day
T111	KEYPHRASE-NOTYPES 2462 2465	IgG
T112	KEYPHRASE-NOTYPES 2469 2472	day
